AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 39 filers reported holding AEVI GENOMIC MEDICINE INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $13,000 | -13.3% | 10,949 | -19.5% | 0.00% | 0.0% |
| Q2 2018 | $15,000 | -70.0% | 13,594 | -67.5% | 0.00% | -50.0% |
| Q4 2017 | $50,000 | -46.8% | 41,879 | -43.9% | 0.00% | -60.0% |
| Q3 2017 | $94,000 | -39.4% | 74,643 | -36.3% | 0.01% | -37.5% |
| Q2 2017 | $155,000 | +76.1% | 117,264 | +146.0% | 0.01% | +100.0% |
| Q1 2017 | $88,000 | – | 47,669 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 128,000 | $142,000 | 0.10% |
| Baker Brothers Advisors | 4,055,142 | $4,501,000 | 0.03% |
| WEDBUSH SECURITIES INC | 209,524 | $233,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,500,000 | $6,105,000 | 0.01% |
| Verity Asset Management, Inc. | 11,500 | $13,000 | 0.01% |
| OneDigital Investment Advisors LLC | 11,437 | $13,000 | 0.00% |
| HYMAN CHARLES D | 15,143 | $17,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 120,619 | $134,000 | 0.00% |
| Legacy Advisors, LLC | 2,450 | $3,000 | 0.00% |
| Kavar Capital Partners, LLC | 1,500 | $2,000 | 0.00% |